We have mutagenized and mapped the gene encoding the large subunit of ribonucleotide reductase (RR1) in pseudorabies virus (PRV; synonyms Aujeszky's disease virus, suid herpesvirus type 1). PRV strains carrying an oligonucleotide that leads to termination of translation of the RRa gene are avirulent for mice. We subsequently constructed a PRV strain carrying a deletion in the RR1 gene and also a PRV strain carrying both the deletion in the RRa gene and a deletion in the glycoprotein gl gene, which is a marker for PRV virulence. Both PRV strains were assayed for virulence and immunogenicity in pigs, the natural host for PRV. In contrast to a markerrescued PRV strain, these RRl-deleted mutants were avirulent, were shed in very low titres in the oropharyngeal fluid by the animals, and induced low titres of neutralizing antibodies. However, protection against clinical signs after infection with virulent PRV was induced by both RRl-deleted mutants. The relative importance of viral RR and thymidine kinase enzymes for deoxynucleotide synthesis in viral replication is discussed. In addition, we discuss the potential use of RR as a target for anti-herpesviral drugs and the use of PRV strains, deleted for the RR 1 gene, as vaccine strains.
Introduction
Ribonucleotide reductase (RR, EC 1.17.4.1) reduces ribonucleoside diphosphates to the corresponding deoxyribonucleoside diphosphates and is an essential constituent of the de novo pathway for deoxyribonucleotide synthesis (for review see Reichard, 1988) . Alpha-and gammaherpesviruses have been shown by biochemical and serological methods, and by sequence analysis, to encode RR (Averett et al., 1983 ; Dutia, 1983 ; Bacchetti et al., 1984 Bacchetti et al., , 1986 Galloway & Swain, 1984; Gibson et al., 1984; Frame et al., 1985; Nikas et al., 1986; Swain & Galloway, 1986; Cohen et al., 1987) . The herpesviral enzymes consist of two non-identical subunits; in herpes simplex virus type 1 (HSV-1) these subunits have been demonstrated to be in an e~fl2 configuration (Ingemarson & Lankinen, 1987) . In HSV-1, the RR subunits are encoded by the genes UL39 (the large subunit, RR1) and UL40 (the small subunit, RR2) (McGeoch et al., 1988) .
RRl-deficient mutants of HSV-1 have been shown to replicate poorly in non dividing (serum-starved) cells, whereas viral growth in dividing cells is found to be much less affected (Goldstein & Weller, 1988a, b; . It is believed that, in dividing ceils, deoxy-"~ Present address: Laboratory of Mutagenesis, Jacques Monod Institute, 2 Place Jussieu, 75251 Paris Cedex 05, France ribonucleotides for replication of these virus mutants are provided by cellular nucleotide metabolism (Goldstein & Weller, 1988 a,b) . HSV-1 RR1 mutants are non-virulent for mice (Cameron et al., 1988; Jacobson et aL, 1989; Brandt et al., 1991) . However, it was also found that an HSV-1 RR 1 mutant strain is able to cause ulcerative skin lesions in guinea-pigs as severe as wild-type (wt) HSV-1 (Turk et al., 1989) . This apparent contradiction may be explained by the reported poor replication of HSV-1 RR 1 mutants in mouse cells compared to cells of other species (Jacobson et at., 1989; Turk et al., 1989; Brandt et al., 1991) . This stresses the importance of using the natural host in assessing the role of viral RR in virulence. As a consequence, the value of inhibitors of the herpesvirat RR enzyme as anti-herpesviral drugs (Spector et al., 1985; Cohen et al., 1986; Dutia et al., 1986; Turk et al., 1986a, b; Shipman et al., 1986; McClements et al., 1988) is as yet uncertain.
Using biochemical and serological analyses the alphaherpesvirus pseudorabies virus (PRV), the causative agent of Aujeszky's disease (Baskerville et al., 1973; BenPorat & Kaplan, 1985) , has been demonstrated to encode RR (Lankinen et at., 1982; Cohen et al., 1987) . Here, we report the mutagenization and mapping of PRV RR 1. These mutants proved avirulent for mice. To assess the virulence of PRV RR1 mutants for the natural host, pigs, and the immunological protection that is induced by (a) . UL, Unique long region; Us, unique short region; IR and TR, internal and terminal repeat, respectively. BamHI sites are indicated by bars; numbering of BamHI fragments is according to . (b) Cloned fragments used to regenerate PRV by cotransfection (adapted from van Zijl et al., 1988) . (c) c-448, a derivative of c-27 subjected to oligonucleotide insertion mutagenesis. The approximate locations of the PRV homologues of HSV-1 genes UL39 (RR 0 and UL40 (RR~), and the location of the gene for glycoprotein gIII, the homologue of the HSV-1 gC (UL44) gene, are indicated. Vertical arrows above the line indicate oligonucleotide insertion sites relevant to this study. B, BamHI; Bg, BglII; K, KpnI; S, ScaI. The location of probes used for Northern blotting is indicated (dots). The putative layout of the transcripts for the PRV RR genes is shown below (horizontal arrows).
these mutant strains, we constructed a PRV mutant carrying a deletion in the PRV RR 1 gene. Since the PRV glycoprotein gl is a determinant of PRV virulence and neuropathogenicity (Mettenleiter et al., 1987; Quint et al., 1987; Moormann et al., 1990; Card et al., 1992; Kimman et al., 1992) and is used as a serological marker for vaccine strains of PRV (van Oirschot et al., 1986) , we also constructed a double mutant containing deletions of both the RR 1 and gl genes. These mutants and also a PRV strain, rescued for the RR 1 deletion, were assayed for virulence and induction of protective immunity in pigs.
Methods

Cells and viruses.
All PRV strains used in this study are derived from the highly virulent PRV strain NIA-3 (Baskerville et al., 1973) . Porcine kidney cell lines PK15 and SK6 were used for transfections and for virus growth and RNA isolation, respectively. Cells were grown at 37 °C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % fetal calf serum and antibiotics.
Construction of PRV mutants. The method of construction and characterization of oligonucleotide-containing derivatives of PRV cosmid clone c-448, which carries a subgenomic region of the PRV genome of 41 kbp (Fig. 1 b) , was described recently (de Wind et al., 1990 . The inserted oligonucleotide contains translational stop codons in all six reading frames as well as an EcoRI site which is not present in wt PRV. Insertion of the oligonucleotide within a coding sequence thus leads to premature termination of translation. The positions of the oligonucleotide insertions relevant to this study are indicated in Fig. 1 (c) . Viable virus mutants, carrying the inserted oligonucleotide, were regenerated by cotransfection of the oligonucleotide containing a c-448 derivative with three overlapping cloned viral fragments (Fig. lb; van Zijl et al., 1988) . These four cloned fragments together comprise all the PRV genomic information.
DNA sequencing. Cloned fragments containing the DNA region of interest were sequenced after subcloning into M13mpl9. Sequencing according to the method of Sanger et al. (1977) was performed using the T7 sequencing kit from Pharmacia with 7-deaza-2'dGTP substituting for dGTP. Sequencing products were analysed on 6% polyacrylamide gels containing 8 M-urea at 55 °C on a Macrophor electrophoresis unit (LKB Instruments).
Computer analyses. Sequence data were analysed using the PC/gene software package (Intelligenetics and Genofit).
Isolation of mRNA, gel electrophoresis and Northern blotting.
Cytoplasmic RNA was isolated from SK6 cells after infection with wt PRV for 2 or 6 h at an m.o.i, of 10. RNA was electrophoresed on 1% agarose-formaldehyde gels. Blotting was performed on nitrocellulose membranes (Schleicher & Schuell) . DNA fragments to be used as probes were purified free from vector sequences by gel electrophoresis and glass-bead elution (Geneclean, and labelled with [a-3~P]dATP by random priming. Protocols used for RNA isolation, gel electrophoresis, blotting, labelling and hybridization were essentially as described by (Sambrook et al. (1989) .
Analysis of virulence of PRV RR mutants for mice. Mutant c-448 derivatives (10 G p.f.u.) were inoculated subcutaneously in the neck, in a volume of 100 gl, in six BALB/c mice. Mice were monitored for clinical symptoms and death at 8 h intervals.
Analysis of virulence and immunogenicity for pigs.
Virulence of PRV strains for pigs was determined as described Kimman et al., 1992) . Briefly, for each PRV strain, five or six 3-weekold specific pathogen-free Dutch Landrace pigs, which were free from antibodies to PRV, were inoculated intranasally with 1 ml DMEM containing 105 p.f.u, of a PRV strain. One group of pigs was not inoculated, to serve as a control. Three months later, surviving animals were challenged with 1 ml DMEM containing 105 p.f.u, of virulent wt PRV strain NIA-3. Body temperature was monitored daily from 2 days before until 14 days after both inoculations. Fever was defined as a rectal temperature > 40 °C (the normal body temperature is 39 °C). Animals were weighed three times a week for the first three weeks after both inoculations, and weekly thereafter. Oropharyngeal swabs were collected daily for 10 days after both inoculations; virus titres were determined on SK6 cells. After both inoculations, pigs were monitored daily for signs of disease. Titres of neutralizing antibodies were determined as described (Kimman et al., 1992) .
Results
Mutagenization and mapping of PR V RR 1
We have recently described mutagenesis of the PRV genomic region that is present in cosmid c-448 ( Fig. 1 b) by insertion, at a random site, of an oligonucleotide containing translational stop codons in all reading frames and an EcoRI site (de Wind et al., 1990 . Insertion of this oligonucleotide in the coding region of a gene leads to termination of translation and, in addition, induces a frameshift. These features lead to truncation of the protein encoded by the gene in which the oligonucleotide is inserted. Viable oligonucleotide-containing virus strains were generated by cotransfection of the insert of the mutant c-448 derivative with the overlapping inserts of cosmids c-179, c-443 and plasmid pN3HB. These fragments together comprise the entire PRV genomic information (van Zijl et al., 1988; Fig. lb) . Cosmid c-448 contains the PRV glycoprotein gIII gene (Fig. 1 c; Robbins et al., 1986; Wathen & Wathen, 1986) , the homologue of HSV-1 glycoprotein gC encoded by gene UL44 (McGeoch et al., 1988) . As the latter gene is located in the vicinity of the HSV-1 RR genes (UL39 and UL40) and alignment has been found between the HSV-1 and PRV genomes in this region (Ben-Porat et al., 1983; Davison & Wilkie, 1983 ; our unpublished results), we anticipated that the PRV RR genes could also be present in c-448. The PRV RR genes were indeed identified by cross-hybridization analysis between PRV probes and cloned fragments derived from HSV-1 strain 17. As PRV probes for this analysis we used short cloned EcoRI-Sau3A fragments, flanking the inserted oligonucleotide in clones c-448-B4, c-448-B23, c-448-B1 and c-448-B6 (Fig. 1 c, hybridization data not shown) . The mapping of RR 1 was confirmed by DNA sequencing of the cloned PRV sequences flanking the insertions in c-448-B23 (at the left side) and in c-448-B1 (at the right side). The resulting DNA sequence is displayed in Fig. 2 . An alignment between the deduced (partial) PRV RR1 amino acid sequence, and the corresponding RR1 amino acid sequences of HSV-1 (Nikas et al., 1986; McGeoch et al., 1988 ) and varicella-zoster virus (VZV; Davison & Scott, 1986; Nikas et al., 1986) , is shown in Fig. 3 . Insertion of the oligonucleotide in the PRV genome introduces a unique EcoRI site which facilitates mapping of the site of insertion. An agarose gel with a BamHI/EcoRI digest of total DNA, isolated from SK6 cells infected with PRV mutants described here, demonstrates this and is depicted in Fig. 4 Fig. 3 . Alignment between the deduced PRV RR 1 protein sequence, flanking insertions 23 and 1 ( Fig. 1 and 2 ) and the homologous sequences of HSV-1 and VZV RR 1. Asterisks indicate amino acids identical between the three protein sequences, dots indicate similar amino acids. The extent of the RR 1 deletion in PRV mutants BA23-1 and BA23-1Agl is indicated: <, start; >, end. Using the flanking probes mentioned above, we hybridized Northern blots containing RNA isolated from wt PRV-infected cells, 2 and 6 h after infection. As shown in Fig. 5 , all probes detected a transcript of approximately 3.7 kb. This transcript, which appears early-late (with the exception of the blot hybridized with probe 4), is expected to encode the RRa subunit. In addition, probe 6 also detects an early transcript of approximately 1 kb, probably encoding the RRz subunit (see also below). Based on the small size of the probe (0"3 kbp; Fig. l c) , the oligonucleotide is probably inserted in the latter gene in PRV mutant B6. A faint late transcript of approximately 5 kb is also seen in all four blots. The transcriptional organization of the PRV RR genes as deduced from these studies is depicted in Fig.  1 (e) . This organization resembles that of the HSV-1 and HSV-2 RR genes, although the RRa transcript is larger in HSV (Anderson et al., 1981; Draper et al., 1982; McLauchlan & Clements, 1982 , 1983a Swain & Galloway, 1986 ; see also Discussion).
Virulence of P R V mutants for mice
PRV mutants B4, B23, B1 and B6 were assayed for virulence in mice. As Table 1 shows, B23, B1 and B6 were avirulent for mice. This indicates that, like HSV-1 RR, PRV RR determines virulence for mice. Mutant B4 showed the same virulence for mice as wt PRV, suggesting that in this PRV mutant the oligonucleotide is inserted 5' of the RR~ open reading frame.
Construction of P R V R R 1 deletion mutants
For its use as a vaccine strain, a PRV RR mutant should not be able to revert. Therefore we deleted a 0.9 kbp fragment from the PRV RR 1 gene by removing the EcoRI-BglII fragment from the mutant cosmid clone c-448-B23 (Fig. 1 c) , and replacing the excised fragment with the corresponding fragment from clone c-448-B1 (Fig. 1 c) . This resulted in a c-448 derivative with a deletion of the RR1 sequences that are located between the oligonucleotide insertion sites in clones c-448-B23 and c-448-B1. It is noted here that the deletion mutant still contains an inserted oligonucleotide, terminating translation at the site of the insertion in mutant B23. A PRV RR1 deletion mutant, named BA23-1, was generated by cotransfection of the RRl-deleted c-448 insert with the inserts from PRV clones c-179, c-443 and pN3HB (Fig. 1 b) .
To ascertain that the deleted region of the PRV genome is responsible for the phenotype of the strain, we rescued the lesion in the latter mutant. This was performed by cotransfection of isolated DNA from mutant BA23-1 with the purified 6 kbp HindIII-EcoRI fragment from clone c-448-B6 (Fig. 1 c, the HindIII site is in the linker that flanks the cloned PRV region in c-448).
Since PRV glycoprotein gl, encoded in the U s region of PRV DNA (Petrovskis et al., 1986) , has been shown to be involved in virulence and neuropathogenicity (Mettenleiter et al., 1987; Quint et al., 1987; Moormann et al., 1990; Card et al, 1992; Kimman et al., 1992) and, in addition, deletion of gl enables serological differentiation between vaccine and wt strains (van Oirschot et al., 1986) , we constructed a PRV strain carrying both the RR1 deletion and a deletion of the gl gene. This was performed by removing a 1.7 kbp fragment located between the DraI site just 5' of the gl gene (Petrovskis et al., 1986; Fig. lb) and the inserted oligonucleotide in pN3HB derivative 324 (de Wind et al., 1990; Fig. lb) . The resulting gl-deleted mutant pN3HB insert was cotransfected with the c-448A23-1, c-179 and c-443 inserts to yield double mutant BA23-1Agl. An agarose gel with B a m H I / E c o R I digests of these PRV deletion mutants, demonstrating the correctness of the restriction pattern, is shown in Fig. 4 . In rapidly dividing SK6 cells, RRa-deleted strains BA23-1 and BA23 1Agl grew to titres of 7-9 and 7.7, respectively, whereas the rescued strain BA23-1 reached a titre of 8"5. This demonstrates Fig. 1 (c) . Arrows indicate the positions of 28S and 18S RNAs (4-7 and 1-9 kb, respectively). that, as in HSV-1, inactivation of the PRV RR 1 gene has no drastic effects on replication in dividing cells.
Virulence of RR 1 deletion mutants for 3-week-old pigs
Severe and typical signs of Aujeszky's disease were observed in 3-week-old pigs inoculated with PRV, generated by cotransfection of wt cloned subgenomic PRV fragments (van Zijl et al., 1988) and with the rescued mutant BA23-1 ( Table 2 ). The pigs had fever from 2 days after infection and shed high titres of virus, some of the pigs vomited or sneezed, and they all showed neurological signs before they died. In contrast, pigs inoculated with both RR 1 mutants remained healthy and retained their appetite. Remarkably, almost no BA23-1Agl, and no BA23-1 mutant virus, was shed in the oropharyngeal fluid (OPF), indicating that replication of RR 1 mutant PRV strains in nasal and oropharyngeal mucosa is very poor. These pigs had very mild fever, and no growth arrest. All of these animals developed low but detectable titres of neutralizing antibodies ( Table 2) .
Immunogenicity of RR 1 deletion mutants in pigs
Although the titre of neutralizing antibodies was low, vaccination with PRV RR 1 mutants protected the pigs against clinical signs upon challenge with wt PRV (Table  3) . In sharp contrast to the unvaccinated animals, most vaccinated animals showed only very mild signs of disease upon challenge. In agreement with this, both the period with fever, and the height of the fever (not shown), were reduced markedly in most vaccinated pigs. Only one animal, vaccinated with the RRI-gl-PRV mutant, showed mild neurological signs of disease (ataxia) after challenge. The absence of significant disease is illustrated by the almost complete absence of growth retardation (less than 1 day) after challenge, whereas non-vaccinated animals suffered a growth retardation of, on average, 11 days. No differences were found in titres of neutralizing antibodies, assayed 3 weeks after the challenge infection, between vaccinated and non-vaccinated animals (Table 3) . 
Discussion
By oligonucleotide insertion mutagenesis of a large subgenomic fragment of PRV, cross-hybridization studies using probes flanking the inserted oligonucleotide and DNA sequence analysis of these probes, we mutagenized and mapped the PRV homologue of HSV-1 RRv The inserted oligonucleotide contains translational stop codons in all reading frames and a unique EcoRI site that was useful for mapping the inserted oligonucleotide and for cloning short flanking probes. In addition, the EcoRI site is convenient for the further manipulation of the PRV gene of interest as exemplified here by deleting a large part of the PRV RRa gene using the inserted EcoRI site in two mutant c-448 derivatives. The PRV RR, subunit was shown before to have a lower apparent M r than its HSV-1 and HSV-2 homologues [tl0K (Cohen et al., 1987) versus 136K to 144K (Galloway et al., 1982; McLauchlan & Clements, 1983b; Frame et al., 1985; Bacchetti et al., 1984 Bacchetti et al., , 1986 Ingemarson & Lankinen, 1987) ]. As is the case with VZV (Nikas et al., 1986) , Epstein-Barr virus (Gibson et al., 1984) and human cytomegalovirus which encodes only a RR 1 homologue; Chee et al., 1990) , this difference in size probably reflects the absence of the 370 amino acid Nterminal domain which has been found in HSV-1 (Nikas et aI., 1986) and HSV-2 (Swain & Galloway, 1986) only, and which has protein kinase activity in HSV-2 (Chung et al., 1989 (Chung et al., , 1990 Ali et al., 1992) . The absence of the Nterminal domain from the PRV protein is supported by the finding that, although the mutagenic oligonucleotide in PRV mutant B4 is inserted only 1 kbp 5' of insertion 23 ( Fig. 1 c and 4) , the insertion is probably not in the RR 1 gene (see Results). Based on our Northern hybridizations it is probable that, as with the other alphaherpesviruses, VZV (Davison & Scott, 1986) , HSV-1 (Draper et al., 1982; Clements 1983 b), and HSV-2 (McLauchlan & Clements, 1983a; Swain & Galloway, 1986) , the transcripts for PRV RR 1 and RR 2 have 3' coterminal ends. The faint late PRV transcript of approximately 5 kb may be the equivalent of a weak 7 kb HSV-1 transcript that initiates further 5' of the RR genes and overlaps both HSV-1 RR genes (Anderson et al., 1981) .
Although in rapidly growing swine kidney cells the viral titre of the RR1 deletion mutants is decreased less than 10-fold, PRV RR1 mutants are avirulent for mice. A similar absence of virulence for mice is observed for HSV-1 RR 1 mutants (Cameron et al., 1988; Jacobson et al., 1989; Brandt et al., 1991) . However, replication of both HSV-1 wt and RR-strains in murine cells has been shown to be poor compared to replication in cells from other species (Jacobson et al., 1989; Turk et al., 1989; Brandt et al., 1991) . In addition, replication of HSV-1 RR mutants was reduced more at elevated temperatures in mouse cells than in cells from other mammals (Jacobson et al., 1989) . In agreement with this, HSV-1 RR 1 mutants show a wt virulence after inoculation in the skin of guinea-pigs (Turk et al., 1989) . This species specificity of virulence stresses the importance of using the natural host for these assays. We therefore investigated the virulence of a PRV RR1 deletion mutant and a double RR1/glycoprotein gl deletion mutant for pigs. Both mutants proved avirulent. Shedding of mutant virus in the OPF was minimal, suggesting poor replication of the mutants in nasal and oropharyngeal mucosa, the site of primary infection. This is remarkable as dividing mucosal epithelial cells would be expected, like dividing cells in vitro, to complement for the inability of virus to synthesize dNTPs via the de novo pathway of nucleotide synthesis. As the nasal epithelium is in constant contact with the open air, the poor replication of the virus is not likely to be due to diminished complementation of the PRV RR mutant by cellular enzymes at elevated temperatures, as was found for HSV-1 RR mutants in cultured cells (Goldstein & Weller, 1988b; Preston et al., 1988; Jacobson et al., 1989) .
Herpesvirus RR mutants are defective in the de novo pathway of biosynthesis of all deoxynucleotides (for review see Reichard, 1988) . Thymidine kinase (TK) mutants are deficient for the salvage pathway of pyrimidine deoxynucleotides (only thymidine in PRV; Jamieson et al., 1974) . The relative importance of both virus-encoded enzymes for deoxynucleotide supply for viral replication may be inferred from the differences in behaviour between TK and RR mutants. Although both HSV-1 TK mutants (Jamieson et al., 1974) and HSV-1 RR mutants (Goldstein & Weller, 1988a, b) grow very poorly in non-dividing cells as compared to dividing cells, growth of HSV-1 TK- (Jamieson et al., 1974) and PRV TK-(McGregor et al., 1985) mutants is normal in exponentially dividing cells that are able to complement the defect in viral deoxyribonucleotide synthesis. This contrasts with RR mutants of both viruses that grow to approximately 10-fold lower titres in most cells (Goldstein & Weller, 1988 a, b; Preston et al., 1988; Jacobson et al., 1989; Brandt et al., 1991; this work) . In addition, it was found recently that in Veto cells the dTTP accumulation that is induced by HSV-1 infection is abolished in an HSV-1 RR mutant but not in a TK mutant (Daikoku et al., 1991) . In agreement with this, the contribution of nucleotides derived from the host genome via the salvage pathway to HSV-2 DNA synthesis is relatively small (Nutter et al., 1985) . In PRV, poor growth of RR-mutants in vivo as compared with TK-mutants may be reflected by the reduced immune response induced by RR-mutants as compared to TKmutants (compare strain BA23-1Agl with TK-gl strain 783 in Moormann et al., 1990) . These data suggest that, both /n vitro and in vivo, the PRV-encoded RR enzyme is more important than the PRV-encoded TK enzyme for replication of the viral DNA.
The importance of PRV RR for growth in vitro and in the natural host, pigs, supports the notion that the use of RR inhibitory drugs (Spector et al., 1985; Cohen et al., 1986; Dutia et al., 1986; Turk et al., 1986a, b; Shipman et al., 1986; McClements et al., 1988) may be a feasible strategy for anti-herpesviral chemotherapy.
Although replication in vivo is probably poor, PRV RR deletion mutants elicit an immunological response, as reflected by the induction of neutralizing antibodies and the partial protection against challenge with virulent PRV. Based on the minimal growth arrest of pigs challenged with virulent PRV, the PRV RR mutants described here yield a protection that is at least similar to some commercially available vaccine strains van Oirschot et al., 1991) . Although protection induced by RR-deleted PRV strains is probably less than that induced by TK mutant strains (Marchioli et al., 1987; Moormann et al., 1990; van Oirschot et al., 1991) , the absence of shedding of RRmutant strains, in contrast to TK-strains , may be advantageous for their use as a vaccine.
We wish to acknowledge C. Meliefste for excellent technical assistance and Dr D. J. McGeoch for HSV-1 DNA clones.
